<DOC>
	<DOCNO>NCT00728078</DOCNO>
	<brief_summary>The purpose investigator ' study prospectively evaluate whether low-dose thalidomide adjuvant therapy improve outcome radiofrequency ablation hepatocellular carcinoma ( HCC ) .</brief_summary>
	<brief_title>Low-Dose Thalidomide Adjuvant Therapy After Radiofrequency Ablation Hepatocellular Carcinoma</brief_title>
	<detailed_description>Our previous study show radiofrequency ablation ( RFA ) effective liver resection small hepatocellular carcinoma ( HCC ) , recurrence rate RFA relatively high . Adjuvant therapy maybe reduce recurrence rate . Phase 1 2 study show thalidomide safety effective treatment HCC , especially small HCC liver cirrhosis . So proposed low-dose thalidomide adjuvant therapy improve disease progress free survival overall survival RFA HCC .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<mesh_term>Liver Neoplasms</mesh_term>
	<mesh_term>Thalidomide</mesh_term>
	<criteria>Age 18 75 year , refuse surgery first recurrence hepatectomy A solitary HCC 3.17.0cm diameter , 23 lesion , sum diameter â‰¤ 7.0cm Lesions visible ultrasound ( US ) acceptable/safe path lesion skin show US No extrahepatic metastasis No image evidence invasion major portal/hepatic vein branch No history encephalopathy , ascites refractory diuretic variceal bleed A platelet count &gt; 40,000/mm3 No previous treatment HCC except liver resection Patient compliance poor Previous concurrent cancer distinct primary site histology HCC , EXCEPT cervical carcinoma situ , treat basal cell carcinoma , superficial bladder tumor ( Ta , Tis &amp; T1 ) . Any cancer curatively treat &gt; 3 year prior entry permitted History cardiac disease : congestive heart failure &gt; New York Heart Association ( NYHA ) class 2 active coronary artery disease ( myocardial infarction 6 month prior study entry permit ) cardiac arrhythmia require antiarrhythmic therapy beta blocker , *calcium channel blocker digoxin uncontrolled hypertension ( failure diastolic blood pressure fall 90 mmHg , despite use 3 antihypertensive drug ) Active clinically serious infection ( &gt; grade 2 National Cancer Institute [ NCI ] Common Terminology Criteria Adverse Events [ CTCAE ] version 3.0 ) Known history human immunodeficiency virus ( HIV ) infection Known Central Nervous System tumor include metastatic brain disease Patients clinically significant gastrointestinal bleeding within 30 day prior study entry Distantly extrahepatic metastasis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2009</verification_date>
	<keyword>hepatocellular carcinoma</keyword>
	<keyword>liver cancer</keyword>
	<keyword>radiofrequency ablation</keyword>
	<keyword>thalidomide</keyword>
</DOC>